Fourth dose of COVID vaccine found to boost protection in patients with rheumatic disease

Patients with autoimmune rheumatic diseases, which include rheumatoid arthritis and other chronic disorders that cause inflammation, are at increased risk of SARS-CoV-2 infection, as well as death due to severe COVID-19. Many patients receive disease-modifying antirheumatic drugs (DMARDs) to treat these conditions, but this treatment has been associated with a blunted response to COVID-19 vaccines.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup